Ticker League

Estimates for UnitedHealth Group (UNH)

Analyst consensus revenue & EPS estimates for UnitedHealth Group (UNH) — Q2 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q2 2026

$4.92

Consensus revenue · Q2 2026

$110.9B

Analysts

16

Last reported

Jul 16, 2026

Before open
Results are in
XP scoring in progress…
Revenue actual$112B
Revenue consensus$110.8B
EPS actual$6.38
EPS consensus$4.94
Revenue surprise: +1.11%EPS surprise: +29.15%

Analyst consensus

Based on estimates from 16 analysts.

  • Revenue$110.9B
  • EPS$4.92
  • EBITDA$9.1B
  • EBIT$8B
  • Net income$4.4B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q2 2026+1.1%+30.0%
  • Q1 2026+2.1%+10.0%
  • Q4 2025-0.5%+0.3%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

No community consensus

No TickerLeague members predicted UnitedHealth Group (UNH) Q2 2026 before it reported.

Analyst price target

Based on price targets from 18 analysts.

Low
$373.00
Consensus
$469.21
Median
$490.00
High
$529.00
Current
$431.31
Upside
+8.8%

Upside calculated vs most recent trading price of $431.31.

Consensus across all covering analysts. See the ranking ›

$469.21+8.79%

Analyst ratings

Consensus: Buy — based on 52 analyst ratings.

Buy 43Hold 7Sell 2

24-month trend

Recent analyst actions

  • Jul 21, 2026MizuhoOutperform
  • Jul 21, 2026JP MorganOverweight
  • Jul 20, 2026BarclaysOverweight
  • Jul 17, 2026UBSBuy
  • Jul 17, 2026Truist SecuritiesBuy
  • Jul 17, 2026RBC CapitalOutperform
  • Jul 17, 2026OppenheimerOutperform
  • Jul 17, 2026Morgan StanleyOverweight
  • Jul 17, 2026KeybancOverweight
  • Jul 16, 2026BairdNeutral

Frequently asked questions